Cargando…

The baseline recurrence risk of patients with intermediate-risk cervical cancer

OBJECTIVE: This study aimed to investigate the prognosis of patients with intermediate-risk cervical cancer and to evaluate the necessity of adjuvant therapy. METHODS: We conducted a retrospective chart review of patients with stage IB–II cervical cancer who underwent type III radical hysterectomy w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoneoka, Yutaka, Kato, Mayumi Kobayashi, Tanase, Yasuhito, Uno, Masaya, Ishikawa, Mitsuya, Murakami, Takashi, Kato, Tomoyasu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Obstetrics and Gynecology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991004/ https://www.ncbi.nlm.nih.gov/pubmed/33752280 http://dx.doi.org/10.5468/ogs.20243

Ejemplares similares

Brain Metastases from Uterine Cervical and Endometrial Cancer
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021)

Variations in Procedures for Ureterolysis with Sharp Dissection in Minimally Invasive Hysterectomy
por: Tanase, Yasuhito, et al.
Publicado: (2022)

Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021)

Reconsideration of Sharp Dissection in Gynecological Surgery
por: Tanase, Yasuhito, et al.
Publicado: (2023)

Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
por: Yoneoka, Yutaka, et al.
Publicado: (2019)

Clear Cell Carcinoma of the Cervix With OHVIRA Syndrome: A Rare Case Report
por: Tanase, Yasuhito, et al.
Publicado: (2021)

Baseline risk of recurrence in stage I–II endometrial carcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2018)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

Prognostic impact of intraoperative peritoneal cytology in interval debulking surgery for pelvic high‐grade serous carcinoma
por: Kojima, Naoki, et al.
Publicado: (2019)

Spontaneous ureteral rupture during concurrent chemoradiotherapy in a woman with uterine cervical cancer
por: Ikeda, Shun-ichi, et al.
Publicado: (2015)

Changes in HER3 expression profiles between primary and recurrent gynecological cancers
por: Kojima, Yuki, et al.
Publicado: (2023)

Identifying selection criteria for non‐radical hysterectomy in FIGO stage IB cervical cancer
por: Kasamatsu, Takahiro, et al.
Publicado: (2019)

Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma
por: Kojima, Yuki, et al.
Publicado: (2023)

A rare case of recurrent ovarian cancer presenting as a round ligament metastasis
por: Togami, Shinichi, et al.
Publicado: (2011)

Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma
por: Yokoi, Akira, et al.
Publicado: (2019)

A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma
por: Takahashi, Kenta, et al.
Publicado: (2018)

Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis
por: Hiranuma, Kengo, et al.
Publicado: (2023)

HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix
por: Mizuno, Takaaki, et al.
Publicado: (2020)

High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022)

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
por: Murakami, Naoya, et al.
Publicado: (2022)

High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer
por: Yazaki, Shu, et al.
Publicado: (2022)

Integrated extracellular microRNA profiling for ovarian cancer screening
por: Yokoi, Akira, et al.
Publicado: (2018)

Now is it time to implement spacers in cervical cancer brachytherapy?
por: Murakami, Naoya, et al.
Publicado: (2022)

Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
por: Uno, Masaya, et al.
Publicado: (2023)

Mismatch Repair Protein Expression in Endometrial Cancer: Assessing Concordance and Unveiling Pitfalls in Two Different Immunohistochemistry Assays
por: Yoshida, Hiroshi, et al.
Publicado: (2023)

AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk
por: Iida, Yuki, et al.
Publicado: (2023)

Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma
por: Kobayashi Kato, Mayumi, et al.
Publicado: (2022)

Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy
por: Tate, Keisei, et al.
Publicado: (2018)

TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
por: Kuno, Ikumi, et al.
Publicado: (2021)

Malignant struma ovarii presenting with follicular carcinoma: A case report with molecular analysis
por: Tsukada, Takafumi, et al.
Publicado: (2019)

Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group
por: Taguchi, Ayumi, et al.
Publicado: (2023)

Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan
por: Ikeda, Yuji, et al.
Publicado: (2016)

Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer
por: Asami, Yuka, et al.
Publicado: (2023)

Salvage para-aortic lymphadenectomy in recurrent cervical cancer after visualization with 3-dimensional computed tomography angiography
por: Kato, Tomoyasu, et al.
Publicado: (2018)

A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with “intentional internal high-dose policy” high-dose-rate interstitial brachytherapy
por: Kashihara, Tairo, et al.
Publicado: (2020)

Analysis of Risk Factors for Lymphatic Metastasis in Endometrial Carcinoma and Utility of Three-Dimensional Magnetic Resonance Imaging in Gynecology
por: Tanase, Yasuhito, et al.
Publicado: (2018)

Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
por: Yoshida, Hiroshi, et al.
Publicado: (2021)

Management of patients with intermediate-risk early stage cervical cancer
por: Cibula, David
Publicado: (2020)

Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy
por: Murakami, Naoya, et al.
Publicado: (2021)

Technical Note: High-Dose-Rate Interstitial Brachytherapy for Pelvic Sidewall Recurrence Using Intraperitoneal Spacers
por: Miyata, Yusaku, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p6j4he9iv4eonmipcmjv8i27sj